These companies have not only delivered positive returns in 2025 but also offer dividend yields above 3%, consistent annual dividend growth, and resilience amid rising trade tensions. If you're ...

Shares of Cartesian Therapeutics climbed after the company announced positive results in a phase 2b trial of its lead cell-therapy candidate. The stock was up 8.3% to $15.60 in morning trading ...

Results showed that CVN293 was generally well-tolerated following single and 14-day multiple dosing, with 100% of participants completing the trial. There were no severe or dose-limiting adverse ...

VIENNA, Austria—The Volt pulsed-field ablation (PFA) system (Abbott) is safe and effective for pulmonary vein isolation in patients with atrial fibrillation (AF), according to results from the VOLT CE ...

Eli Lilly has recently announced several developments, including positive Phase 2 results for their siRNA ... in antimicrobials underscores a forward-thinking approach. Successful clinical trials ...

has assured Nigerians that the ongoing reforms by the Bola Ahmed Tinubu administration would yield positive results for all. Dabiri-Erewa also said that the welfare of Nigerians is the ...

Safety results were consistent with the known profile of the medicine. Palynziq is the first and only enzyme therapy approved to treat adults with PKU. Detailed results from the PEGASUS study will ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a pharmaceutical company offering and researching life-saving medicines ...

“Finally, brothers and sisters, whatever is true, whatever is noble, whatever is right, whatever is pure, whatever is lovely, whatever is admirable—if anything is excellent or praiseworthy ...